FIELD: medicine.
SUBSTANCE: invention relates to a method for inhibiting tumor growth or achieving tumor regression in a subject with epithelial cancer or ovarian tumor expressing ERα, including the injection to the specified subject of a daily oral dose from 100 to 1000 mg of RAD1901 or its pharmaceutically acceptable salt.
EFFECT: growth inhibition or achievement of regression of epithelial cancer or ovarian tumor expressing ERα.
10 cl, 2 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS OF TREATING CDK4/6 INHIBITOR-RESISTANT CANCER | 2019 |
|
RU2820478C2 |
| METHODS FOR TREATING CANCER | 2016 |
|
RU2745678C2 |
| METHODS OF TREATING CANCER ON MODELS HAVING ESR1 MUTATIONS | 2019 |
|
RU2822195C2 |
| METHODS FOR TREATING CANCER | 2016 |
|
RU2747228C2 |
| METHODS OF TREATING CANCER | 2016 |
|
RU2737496C2 |
| COMPLEX THERAPY FOR CANCER TREATMENT | 2018 |
|
RU2810487C2 |
| METHODS OF TREATING AR+ BREAST CANCER | 2017 |
|
RU2769527C2 |
| BENZOTHIOPHENE SELECTIVE ESTROGEN RECEPTOR BLOCKERS | 2016 |
|
RU2747802C2 |
| COMBINATION THERAPY FOR TREATMENT OF MAMMARY GLAND CANCER | 2018 |
|
RU2764724C2 |
| THERAPEUTIC COMBINATIONS CONTAINING RAF INHIBITOR AND ERK INHIBITOR | 2017 |
|
RU2774612C2 |
